Invention Grant
US07888380B2 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives
有权
1,2,4-三唑基氨基芳基（杂芳基）磺酰胺衍生物
- Patent Title: 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives
- Patent Title (中): 1,2,4-三唑基氨基芳基（杂芳基）磺酰胺衍生物
-
Application No.: US11245314Application Date: 2005-10-06
-
Publication No.: US07888380B2Publication Date: 2011-02-15
- Inventor: Shenlin Huang , Ronghui Lin , Peter J. Connolly , Stuart L. Emanuel , Steven A. Middleton , Robert H. Gruninger , Steven K. Wetter
- Applicant: Shenlin Huang , Ronghui Lin , Peter J. Connolly , Stuart L. Emanuel , Steven A. Middleton , Robert H. Gruninger , Steven K. Wetter
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica, N.V.
- Current Assignee: Janssen Pharmaceutica, N.V.
- Current Assignee Address: BE Beerse
- Agency: Patton Boggs LLP
- Main IPC: A61K31/4196
- IPC: A61K31/4196 ; A61K31/496 ; A61K33/42 ; C07D249/14 ; C07D257/04 ; C07F9/572 ; C07F9/6515 ; C07F9/6518 ; C07F9/6509
Abstract:
1,2,4-Triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I), pharmaceutically acceptable salts thereof, processes for the manufacture of 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives and pharmaceutical compositions containing 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives are disclosed: The 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I) possess cell cycle inhibitory activity and are accordingly useful for their anti cell proliferation (such as anti cancer) activity.
Public/Granted literature
- US20060173020A1 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives Public/Granted day:2006-08-03
Information query
